Fam-trastuzumab deruxtecan for Breast Cancer User Reviews

Brand names: Enhertu

Rating: 8.5

Fam-trastuzumab deruxtecan has an average rating of 8.5 out of 10 from a total of 4 reviews for the treatment of breast cancer. 75% of reviewers reported a positive experience, while 0% reported a negative experience.

10		50%
9		25%
8		0%
7		0%
6		0%
5		25%
4		0%
3		0%
2		0%
1		0%

Liz...
December 21, 2023

"It is saving my life & has limited side effects. While I am on it, my tumor did not spread or grow."

10 / 10

Was this helpful?Yes No

5 Report

ALP...
Taken for 1 to 6 months
October 18, 2024

"So far, things have been going well, very few side effects, and my cancer seems to be under control."

9 / 10

Was this helpful?Yes No

2 Report

Jan...
Taken for 1 to 6 months
March 19, 2024

"Only 2 infusions, on Zofran and dexamethasone, caused severe constipation and cramps. Tumor markers next, only 2 infusions."

5 / 10

Was this helpful?Yes No

3 Report

Frequently asked questions

KUM...
Taken for 1 to 2 years
March 30, 2024

"True and Best Injection for HER2-POSITIVE Treatment."

10 / 10

Was this helpful?Yes No

3 Report

Are you taking this medicine?

Your review helps others make informed decisions.

Write a review

Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.